Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Jun-24 4:02 PM View:  | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 13-Jun-24 | Private Purchase | 10,000 | $2.91 | $29,100.00 | < 1% 3.1M to 3.11M | |
| 07-Jun-24 4:02 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 06-Jun-24 | Private Purchase | 20,000 | $3.07 | $61,400.00 | < 1% 3.08M to 3.1M | |
| 23-May-24 4:24 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 21-May-24 | Grant | 56,575 | -- | -- | 11% 499.63K to 556.21K | |
| 23-May-24 4:20 PM View: | Edrick Alan I Director | Harvard Bioscience Inc. (HBIO) | 21-May-24 | Grant | 45,872 | -- | -- | 20% 228.04K to 273.91K | |
| 23-May-24 4:22 PM View: | Eade Katherine A. Director | Harvard Bioscience Inc. (HBIO) | 21-May-24 | Grant | 45,872 | -- | -- | 17% 265.25K to 311.13K | |
| 23-May-24 4:23 PM View: | Loewald Thomas W Director | Harvard Bioscience Inc. (HBIO) | 21-May-24 | Grant | 45,872 | -- | -- | 18% 249.44K to 295.31K | |
| 07-Mar-24 4:04 PM View: | Cote Jennifer Chief Financial Officer | Harvard Bioscience Inc. (HBIO) | 06-Mar-24 | Payment of Exercise | 9,920 | $4.11 | $40,771.20 | (6%) 178.66K to 168.74K | |
| 07-Mar-24 4:04 PM View: | Cote Jennifer Chief Financial Officer | Harvard Bioscience Inc. (HBIO) | 05-Mar-24 | Grant | 71,600 | -- | -- | 67% 107.06K to 178.66K | |
| 07-Mar-24 4:03 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 05-Mar-24 | Grant | 429,594 | -- | -- | 16% 2.65M to 3.08M | |
| 03-Jan-24 5:18 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 31-Dec-23 | Payment of Exercise | 82,790 | $5.35 | $442,926.00 | (3%) 2.73M to 2.65M | |
| 03-Jan-24 5:17 PM View: | Cote Jennifer Chief Financial Officer Director | Harvard Bioscience Inc. (HBIO) | 29-Dec-23 | Payment of Exercise | 5,910 | $5.35 | $31,618.50 | (5%) 112.97K to 107.06K | |
| 03-Jan-24 5:18 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 29-Dec-23 | Payment of Exercise | 128,392 | $5.35 | $686,897.00 | (4%) 2.86M to 2.73M | |
| 21-Aug-23 4:06 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 17-Aug-23 | Private Purchase | 25,000 | $4.38 | $109,500.00 | < 1% 2.84M to 2.86M | |
| 13-Jun-23 4:02 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 11-Jun-23 | Payment of Exercise | 48,373 | $5.46 | $264,117.00 | (2%) 2.89M to 2.84M | |
| 23-May-23 4:09 PM View: | Edrick Alan I Director | Harvard Bioscience Inc. (HBIO) | 22-May-23 | Grant | 25,554 | -- | -- | 13% 202.49K to 228.04K | |
| 23-May-23 4:07 PM View: | Eade Katherine A. Director | Harvard Bioscience Inc. (HBIO) | 22-May-23 | Grant | 25,554 | -- | -- | 11% 239.7K to 265.25K | |
| 23-May-23 4:04 PM View: | Loewald Thomas W Director | Harvard Bioscience Inc. (HBIO) | 22-May-23 | Grant | 25,554 | -- | -- | 11% 223.88K to 249.44K | |
| 23-May-23 4:03 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 22-May-23 | Grant | 31,516 | -- | -- | 7% 468.12K to 499.63K | |
| 15-Mar-23 10:00 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 15-Mar-23 | Purchase | 20,000 | $2.60 | $52,000.00 | < 1% 2.87M to 2.89M | |
| 16-Mar-23 10:00 PM View: | Edrick Alan I Director | Harvard Bioscience Inc. (HBIO) | 15-Mar-23 | Purchase | 16,192 | $2.62 | $42,423.00 | 9% 186.29K to 202.49K | |
| 16-Mar-23 10:00 PM View: | Edrick Alan I Director | Harvard Bioscience Inc. (HBIO) | 14-Mar-23 | Private Purchase | 13,808 | $2.67 | $36,867.40 | 8% 172.49K to 186.29K | |
| 15-Mar-23 10:00 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 14-Mar-23 | Private Purchase | 20,000 | $2.67 | $53,400.00 | < 1% 2.85M to 2.87M | |
| 08-Mar-23 5:01 PM View: | Cote Jennifer Interim CFO | Harvard Bioscience Inc. (HBIO) | 06-Mar-23 | Grant | 82,634 | -- | -- | 272% 30.33K to 112.97K | |
| 08-Mar-23 5:02 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 06-Mar-23 | Grant | 692,750 | -- | -- | 32% 2.15M to 2.85M | |
| 03-Jan-23 6:14 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 01-Jan-23 | Payment of Exercise | 49,322 | $2.77 | $136,622.00 | (2%) 2.2M to 2.15M | |
| 03-Jan-23 6:16 PM View: | Rossi Michael A. Chief Financial Officer | Harvard Bioscience Inc. (HBIO) | 29-Dec-22 | Payment of Exercise | 9,960 | $2.55 | $25,398.00 | (4%) 270.5K to 260.54K | |
| 03-Jan-23 6:14 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 29-Dec-22 | Payment of Exercise | 76,187 | $2.55 | $194,277.00 | (3%) 2.28M to 2.2M | |
| 02-Dec-22 4:01 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 01-Dec-22 | Purchase | 15,000 | $2.61 | $39,150.00 | < 1% 2.26M to 2.28M | |
| 02-Dec-22 4:01 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 30-Nov-22 | Private Purchase | 15,000 | $2.41 | $36,150.00 | < 1% 2.25M to 2.26M | |
| 15-Sep-22 4:02 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 06-Sep-22 | Disposition (other) | 108,715 | -- | -- | (19%) 576.83K to 468.12K | |
| 29-Aug-22 5:24 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 26-Aug-22 | Private Purchase | 9,291 | $3.41 | $31,682.30 | 2% 458.83K to 468.12K | |
| 26-Aug-22 4:02 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 25-Aug-22 | Purchase | 8,244 | $3.34 | $27,535.00 | 2% 450.58K to 458.83K | |
| 26-Aug-22 4:02 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 24-Aug-22 | Private Purchase | 17,291 | $3.23 | $55,849.90 | 4% 433.29K to 450.58K | |
| 24-Aug-22 4:06 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 23-Aug-22 | Purchase | 8,939 | $3.23 | $28,873.00 | 2% 424.35K to 433.29K | |
| 24-Aug-22 4:06 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 22-Aug-22 | Private Purchase | 4,918 | $3.16 | $15,540.90 | 1% 419.43K to 424.35K | |
| 22-Aug-22 4:08 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 19-Aug-22 | Purchase | 9,608 | $3.28 | $31,514.20 | 2% 409.83K to 419.43K | |
| 22-Aug-22 4:08 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 18-Aug-22 | Private Purchase | 1,151 | $3.19 | $3,671.69 | < 1% 408.68K to 409.83K | |
| 18-Aug-22 4:19 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 17-Aug-22 | Private Purchase | 40,000 | $3.19 | $127,600.00 | 2% 2.21M to 2.25M | |
| 20-Jul-22 4:25 PM View: | Rossi Michael A. Chief Financial Officer | Harvard Bioscience Inc. (HBIO) | 18-Jul-22 | Payment of Exercise | 7,008 | $3.63 | $25,439.00 | (3%) 277.51K to 270.5K | |
| 12-Jul-22 4:03 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 08-Jul-22 | Payment of Exercise | 92,771 | $3.90 | $361,807.00 | (4%) 2.3M to 2.21M | |
| 17-Jun-22 4:00 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 15-Jun-22 | Private Purchase | 30,000 | $3.71 | $111,300.00 | 1% 2.27M to 2.3M | |
| 14-Jun-22 4:08 PM View: | Rossi Michael A. Chief Financial Officer | Harvard Bioscience Inc. (HBIO) | 11-Jun-22 | Payment of Exercise | 6,325 | $3.95 | $24,983.80 | (2%) 283.83K to 277.51K | |
| 14-Jun-22 4:07 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 11-Jun-22 | Payment of Exercise | 48,373 | $3.95 | $191,073.00 | (2%) 2.32M to 2.27M | |
| 26-May-22 4:04 PM View: | Edrick Alan I Director | Harvard Bioscience Inc. (HBIO) | 24-May-22 | Grant | 38,259 | -- | -- | 29% 134.23K to 172.49K | |
| 26-May-22 4:02 PM View: | Eade Katherine A. Director | Harvard Bioscience Inc. (HBIO) | 24-May-22 | Grant | 38,259 | -- | -- | 19% 201.44K to 239.7K | |
| 26-May-22 4:06 PM View: | Loewald Thomas W Director | Harvard Bioscience Inc. (HBIO) | 24-May-22 | Grant | 38,259 | -- | -- | 21% 185.63K to 223.88K | |
| 26-May-22 10:00 PM View: | Loy Bertrand Director | Harvard Bioscience Inc. (HBIO) | 24-May-22 | Grant | 47,493 | -- | -- | 13% 361.18K to 408.68K | |
| 10-May-22 5:13 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 09-May-22 | Purchase | 10,000 | $3.40 | $34,000.00 | < 1% 2.31M to 2.32M | |
| 10-May-22 5:13 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 06-May-22 | Private Purchase | 30,000 | $3.78 | $113,400.00 | 1% 2.28M to 2.31M | |
| 03-Mar-22 9:13 PM View: | Green James W Chief Executive Officer Director | Harvard Bioscience Inc. (HBIO) | 01-Mar-22 | Grant | 302,402 | -- | -- | 15% 1.98M to 2.28M |
